[
    [
        {
            "time": "",
            "original_text": "这只大跌的ETF近两日流入了十个亿",
            "features": {
                "keywords": [
                    "ETF",
                    "大跌",
                    "流入",
                    "十个亿"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "基金"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "这只大跌的ETF近两日流入了十个亿",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "康泰生物：仅使用部分车间即满足年产至少2亿剂新冠疫苗产能",
            "features": {
                "keywords": [
                    "康泰生物",
                    "新冠疫苗",
                    "产能",
                    "2亿剂"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物：仅使用部分车间即满足年产至少2亿剂新冠疫苗产能",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康泰生物在互动平台表示，目前根据与阿斯利康的合作，公司仅使用了部分车间以满足至少2亿剂疫苗的生产能力",
            "features": {
                "keywords": [
                    "康泰生物",
                    "阿斯利康",
                    "合作",
                    "新冠疫苗",
                    "生产能力",
                    "2亿剂"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物在互动平台表示，目前根据与阿斯利康的合作，公司仅使用了部分车间以满足至少2亿剂疫苗的生产能力",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]